Approval · Notice of Compliance 32811 · 2024
NEXPLANON: Notice of Compliance 32811
Issued March 1, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32811
- Date
- March 1, 2024
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NEXPLANON | Not yet assigned | — |
Medicinal ingredients
- ETONOGESTREL 68 MG per IMP